Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Treatment of polydipsia and hyponatremia in psychiatric patients can clozapine be a new option

  • Jose De Leon
  • , Cherian Verghese
  • , Joseph K. Starnila
  • , Theodore Lawrence
  • , George M. Simpson

Producción científica: Articlerevisión exhaustiva

60 Citas (Scopus)

Resumen

Polydipsia occurs frequently in chronic schizophrenic patients, some of whom develop intermittent hyponatremia. Most therapeutic efforts have tried to control the hyponatremia. Four schizophrenic patients, followed for more than one year, showed improvement on clozapine. Case 1 was an outpatient without history of hyponatremia who improved from polydipsia and psychosis. The last three were inpatients with polydipsia, intermittent hyponatremia, and psychosis who showed minimal improvement of psychosis but significant decrease in polydipsia and water intoxication. Case 2 relapsed to polydipsia when clozapine was discontinued on two occasions. Case 3 demonstrated polyuria during 39% of days before clozapine and in 0% of days after two weeks of clozapine. In case 4, most baseline sodium levels were abnormal, but all became normal after clozapine. A time-series analysis for intervention effects showed a significant effect of clozapine (p =. 017). The limited information provided by these case reports suggest the need for controlled studies of the clozapine effect on polydipsic patients.

Idioma originalEnglish
Páginas (desde-hasta)133-138
Número de páginas6
PublicaciónNeuropsychopharmacology
Volumen12
N.º2
DOI
EstadoPublished - abr 1995

Nota bibliográfica

Funding Information:
The authors are grateful to Marion Wilson, R.N., Sudhir Stokes, M.D., and to the staff of Haverford and Norristown State Hospital Research Units for their help with the patients. Ken H. Gilman and Robert Blake, medical students, were recipients of the Stanley Foundation Fellowship when they were working on this project. This study was partially supported by a PAL NIMH grant (MH 45190). Cherian Verghese, M.D. had additional support from a NARSAD grant.

Financiación

The authors are grateful to Marion Wilson, R.N., Sudhir Stokes, M.D., and to the staff of Haverford and Norristown State Hospital Research Units for their help with the patients. Ken H. Gilman and Robert Blake, medical students, were recipients of the Stanley Foundation Fellowship when they were working on this project. This study was partially supported by a PAL NIMH grant (MH 45190). Cherian Verghese, M.D. had additional support from a NARSAD grant.

FinanciadoresNúmero del financiador
PAL NIMHMH 45190
National Alliance for Research on Schizophrenia and Depression

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Pharmacology
    • Psychiatry and Mental health

    Huella

    Profundice en los temas de investigación de 'Treatment of polydipsia and hyponatremia in psychiatric patients can clozapine be a new option'. En conjunto forman una huella única.

    Citar esto